News
There is nothing else that can compare to GLP-1 drugs such as semaglutide
Elon Musk has been appointed as the co head of the newly established Department of Government Efficiency in the administration of newly elected President Donald Trump. He publicly expressed his support for weight loss drugs on Wednesday, December 11th.
"Nothing can improve the health, life span and quality of life of Americans better than making [GLP-1 drug] extremely cheap for the public. Nothing else can compare to it, "Musk wrote in his post on X.
However, after Musk supported GLP-1 drugs, Robert Kennedy (RFK Jr.) expressed a slightly different view on his previous remarks in a television interview at the New York Stock Exchange on Thursday, stating that weight loss drugs may "ultimately have a place. The first line of defense should be lifestyle, eating well to ensure you don't become obese, and those GLP-1 drugs should have a place, "he said.
As the head of the Department of Health and Human Services, Robert Kennedy will supervise institutions such as Medicare and Medicaid, which manage the health insurance of millions of Americans, and the Food and Drug Administration, which is responsible for approving new drugs or expanding the use of existing drugs, if they are proved to be safe and effective.
This is not the first time Musk has expressed support for the use of these popular therapies. In 2022, he posted on X claiming that he had used Wegovy. Recently, he agreed with Senator Bernie Sanders' efforts to reduce the cost of expensive GLP-1 drugs.
"Solving the obesity problem can greatly reduce the risk of suffering from other diseases, especially diabetes, and improve the quality of life. We really need to find a way to let anyone who wants to get appetite inhibitors. I disagree with Bernie on many things, but I agree with him on this point." Musk wrote in a post in September.
Research shows that in addition to weight loss and control of type 2 diabetes, these drugs can also prevent hypertension, liver disease, kidney disease and other health complications caused by obesity.
CATEGORIES
News
- About semaglutide2024-12-20
- Semaglutide is a weekly GLP-1RA that has2024-12-19
- There is nothing else that can compare t2024-12-18
- About Semaglutide2024-12-12
- The use of GLP-1 drugs such as semagluti2024-12-11
CONTACT US
Contact: NewPeptides
Phone: +852 6902 7583
E-mail: Linda@goodpeptides.com
Add: Science and Technology Industrial Park, Yuelu District, Changsha City, Hunan Province